Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.

Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood). 2007 Jan-Feb; 26(1):186-94.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.